Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Stealth BioTherapeutics received early financing of $100.0M on 2018-06-18.
| Series | Round size | Date |
|---|---|---|
| Convertible Note | $100M | 06/2018 |
| Post Ipo Equity | $20M | 04/2020 |
| Post Ipo Equity | $3.2M | 11/2020 |
| Post Ipo Equity | $4.7M | 02/2021 |
| Post Ipo Equity | $30M | 05/2021 |
| Post Ipo Debt | $25M | 10/2021 |
| Investors | Security type |
|---|---|
| BVCF MANAGEMENT LTD | Convertible Note |
| Ocean Equity Partners | Convertible Note |
| CMBC Capital Holdings | Convertible Note |
| Kingdon Capital | Convertible Note |
| SAGAMORE INVESTMENTS INC | Convertible Note |
| Atlantis Investment Management | Convertible Note |
| PIVOTAL BIOVENTURE PARTNERS | Convertible Note |
| Morningside Venture Investments | Post Ipo Equity |
| Morningside Venture Investments | Post Ipo Equity |
| Horizon Technology Finance | Post Ipo Debt |
Stealth BioTherapeutics's top competitor, XORTX Therapeutics, earned an annual revenue of $6.2B.
Stealth BioTherapeutics's smallest competitor is Edgewise Therapeutics with revenue of $30.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Edgewise Therapeutics | - | $30,000 | 45 | - |
| Arrakis Therapeutics | - | $1.0M | 78 | - |
| Glycomine | - | $400,000 | 8 | - |
| Neurana Pharmaceuticals | - | $670,000 | 15 | - |
| XORTX Therapeutics | - | $6.2B | 2 | - |
| Ancora Pharmaceuticals | - | $670,000 | 1 | - |
| Seelos Therapeutics | - | $375,000 | 10 | - |
| Cerecor | - | $6.7M | 32 | - |
Zippia gives an in-depth look into the details of Stealth BioTherapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Stealth BioTherapeutics. The employee data is based on information from people who have self-reported their past or current employments at Stealth BioTherapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Stealth BioTherapeutics. The data presented on this page does not represent the view of Stealth BioTherapeutics and its employees or that of Zippia.
Stealth BioTherapeutics may also be known as or be related to STEALTH BIOTHERAPEUTICS CORP, Stealth BioTherapeutics, Stealth BioTherapeutics Inc, Stealth BioTherapeutics Inc. and Stealth Biotherapeutics.